Location History:
- Beverly, MA (US) (1994)
- Richmond, CA (US) (2002 - 2008)
Company Filing History:
Years Active: 1994-2008
Title: Thomas G. Gesner: Innovator in Megakaryocyte Stimulating Factors
Introduction
Thomas G. Gesner is a notable inventor based in Richmond, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides related to human megakaryocyte stimulating factors (MSFs). With a total of 4 patents to his name, Gesner's work has the potential to impact pharmaceutical compositions and therapeutic methods.
Latest Patents
Among his latest patents, Gesner has focused on the creation of pharmaceutical compositions that contain novel polypeptides of human megakaryocyte stimulating factors. These innovations provide methods for their preparation and use, showcasing his commitment to advancing medical science.
Career Highlights
Gesner is currently associated with Genetics Institute, Inc., where he continues to push the boundaries of research and development in his field. His work has garnered attention for its potential applications in medicine and therapeutic treatments.
Collaborations
Some of his notable coworkers include Katherine Jane Turner and Steven C. Clark, who have collaborated with him on various projects, contributing to the innovative environment at Genetics Institute, Inc.
Conclusion
Thomas G. Gesner's contributions to the field of biotechnology, particularly through his patents on megakaryocyte stimulating factors, highlight his role as a key innovator. His work continues to pave the way for advancements in pharmaceutical applications.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.